Myocardial Ischemia

The FDA approved 18F flurpiridaz, a new cardiac PET perfusion radiotracer, for adult patients with known or suspected coronary artery disease being evaluated for myocardial ischemia and infarction.

Overreliance on high-sensitivity troponin as the sole assay to diagnose heart attacks has led to a rise in misdiagnosis, which is not benign and burdens the health system and patients with unnecessary and sometimes invasive testing.

ATLANTA — Use of a coronary sinus reducer improved chest pain symptoms and quality of life for patients with significant coronary artery disease, despite not improving myocardial blood flow, a speaker reported.

An FDA advisory committee voted 8-3 against supporting the approval of the HF drug omecamtiv mecarbil, with panelists citing a small observed benefit for a limited group of patients.

Most women with myocardial ischemia without obstructive CAD attending a dedicated women’s heart center received new or changed diagnoses and reported decreased chest pain and other improved outcomes at 1 year, researchers reported.

Early revascularization may confer mortality benefit in patients with moderate to severe myocardial ischemia identified on nuclear stress testing, regardless of left ventricular ejection fraction, researchers reported.

Menopause can be a good time to start addressing CVD risk reduction even though it should be discussed way before then, according to a presentation at the virtual Heart in Diabetes Conference.

A novel method that incorporates information from cardiac CT and cardiac MRI aided cardiologists in diagnosing CAD, according to a study published in Radiology: Cardiothoracic Imaging.